EpiCypher develops kits and workflows that enable researchers to make discoveries in genomic mapping of epigenetic marks and transcription factors. Researchers working in various fields from cancer, immunology to aging research are interested in genomic mapping. These are not trivial protocols to conduct and hence EpiCypher is creating and optimizing assays that researchers can easily implement. EpiCypher is most known for their CUTANATM CUT&RUN assays - an innovative protocol that provides chromatin binding information with fewer input cells than traditional chromatin-immunoprecipitation methods.

EpiCypher

Founded: 2012
Location: Raleigh, NC
Employee range: 11 - 50
Funding: &lt;10M

Short description:

Drug notes:

Long description:

Jobs: